Berinert®
Manufacturer: CSL Behring
Generic Name: C1-Esterase Inhibitor (Human)
Indications: Berinert
® is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. The safety and efficacy of Berinert
® for prophylactic therapy have not been established. For indications, dosing and other information, please refer to the manufacture package insert.
| Product |
Size |
NDC |
PI |
MSDS |
|
Berinert® C-1 Esterase Inhibitor |
500 unit vial |
63833-0825-02 |
PI |
MSDS |
Clinical Data: For any Questions or for further information related to
Berinert
®, C-1 Esterase Inhibitor (Human) clinical pharmacology, additional indications and usages, contraindications, warnings, precautions, adverse reations, dosage, administration and/or storage of this product, please
contact BDI Pharma or call 1-800-948-9834